Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by Tropicalsunon Jul 05, 2022 6:16pm
105 Views
Post# 34803492

RE:VMD publishes study demonstrating the benefits of NIVH

RE:VMD publishes study demonstrating the benefits of NIVHSo this is the third published study where measureable medical research shows that lives are saved, hospital readmission is reduced and money per patient is saved. Now it may not be a huge amount of money being saved, but the main objective should be that it saves lives and keeps these patients out of the hospital.

Can someone explain to me what Viemed is expecting to achieve with these studies? Does this all but gaurantee a VA contract that has been in the works now for a few years? Does this convince more doctors that may still be on the sidelines to prescribe this treatment. Does this prove once and for all to CMS that this treatment works. How many peer reviewed medical papers have to be written to prove the facts that this treatment works to save lives, save money and reduce hospital readmission?

Obviously for shareholders, we hope this leads to big contracts very quickly. My guess is that is wishful thinking.
<< Previous
Bullboard Posts
Next >>